Follow the ブライトパス・バイオ share price and the full insider trade history of the company, a listed equity based in Japan. Shares are listed on the JP market, under the oversight of EDINET (Japan FSA). Market capitalisation: €6.5bn. The latest transaction was disclosed on 19 February 2026 (Holding update). Among the most active insiders: Phillip Securities Japan,Ltd.. The full history is free.
8
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,876 of 29,064 companies
26.3
score / 100
Value
10
Quality
42
FCF yld-21%
Earn yld-20%
EV/EBITDA·
ROE-79%
Gross mgn64%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.